Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

G150

Sigma-Aldrich

Granulocyte Chemotactic Protein-2 human

>97% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, suitable for cell culture

Synonym(s):

GCP-2

Sign Into View Organizational & Contract Pricing


About This Item

MDL number:
UNSPSC Code:
51111800

biological source

human

recombinant

expressed in E. coli

assay

>97% (SDS-PAGE)

form

lyophilized powder

potency

1.17 μg/mL

packaging

pkg of 25 μg

technique(s)

cell culture | mammalian: suitable

impurities

endotoxin, tested

UniProt accession no.

storage temp.

−20°C

Gene Information

human ... CXCL6(6372)

General description

GCP2 (granulocyte chemotactic protein 2) is a chemotactic chemokine and is expressed in mesenchymal cells and endothelial cells and fibroblasts showing angiogenic characteristics. It is a pro-inflammatory neutrophil chemoattractant. It is a member of the ELR+ (glutamic acid-leucine-arginine) CXC family, and shares the highest structural homology to IL-8 (interleukin 8).

Biochem/physiol Actions

GCP2 (granulocyte chemotactic protein 2) up-regulation in tumor cell allografts results in enhanced angiogenesis. It functions synergistically with MCP-1 (monocyte chemoattractant protein) chemokines to induce neutrophil mobilization and tumor angiogenesis. This protein is present in amniotic fluid, and this concentration decreases with advancing stages of gestation. Thus, it is thought to confer immune protection against invading microbes in the amniotic cavity. In diseased gingival tissues, it works in orchestration with IL-8 (interleukin 8), which is linked to the severity of periodontal disease. This protein is also involved in antibacterial activity during localized infection.

Physical form

Lyophilized from a 0.2 μm filtered solution of 30% acetonitrile and 0.1% trifluoroacetic acid containing 1.25 mg bovine serum albumin

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

R P Johnson et al.
The Journal of biological chemistry, 275(1), 95-105 (2000-01-05)
The tail domain of vinculin (V(t)) is an actin binding module containing two regions that interact with F-actin. Although intact V(t) purified from a bacterial expression system is a globular monomer, each actin binding region dimerizes when expressed individually, suggesting
Bulei Wang et al.
Carbohydrate polymers, 246, 116620-116620 (2020-08-05)
In this study, a water-soluble polysaccharide (BSP) was extracted and purified from pseudobulb of Bletilla striata. The preliminary structure and gastroprotective activity of BSP were analyzed. Results indicate that BSP is a glucomannan with a molar ratio of 7.45:2.55 (Man:Glc)
Vladimir A Ledov et al.
Vaccine, 37(8), 1062-1072 (2019-01-24)
Shigellosis, a major cause of diarrhea worldwide, exhibits high morbidity and mortality in children. Specificity of Shigella immunity is determined by the structure of the main protective O-antigen polysaccharide component incorporated into the lipopolysaccharide (LPS) molecule. Endotoxicity, however, precludes LPS
Sung-Whan Kim et al.
Cardiovascular research, 95(4), 495-506 (2012-08-14)
In this study, our aim was to evaluate the angio-vasculogenic properties of human adipose tissue-derived mesenchymal stem cells overexpressing the granulocyte chemotactic protein (GCP)-2 (hASCs/GCP-2) and to determine possible therapeutic effects in an experimental ischaemic heart model. Quantitative real-time (qRT)-PCR
Himanshu Mishra et al.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 13(4), 495-509 (2010-01-01)
Solid lipid nanoparticles (SLN) have emerged as carriers for therapeutic peptides, proteins, antigens and bioactive molecules. We have explored the potential of SLN as carrier for Hepatitis B surface antigen (HBsAg) by surface modifications to enhance their loading efficiency and

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service